Hypertensive disorders of pregnancy associated with adverse pregnant outcomes in patients with systemic lupus erythematosus: a multicenter retrospective study

Clinical Rheumatology
Dongying ChenZhongping Zhan

Abstract

Hypertension disorders in pregnancy (HDP) were common complications in women with systemic lupus erythematosus (SLE). However, the impact of HDP and the measures to prevent HDP-related fetal adverse pregnancy outcomes (APOs) remained to be explored. A multicenter retrospective study of 342 pregnant women with SLE was performed. Variables related to SLE and APOs were recorded. Fetal development was evaluated by umbilical artery Doppler ultrasonography. HDP was diagnosed in 45 (13.2%) patients, including pre-eclampsia in 42 and gestational hypertension in 3. Patients with HDP had higher incidence of preterm birth (71.1% vs 20.9%, P < 0.001), intrauterine growth retardation (IUGR) (37.8% vs 11.8%, P < 0.001), low-birth-weight infants (62.2% vs 17.2%, P < 0.001), and very-low-birth-weight infants (37.8% vs 2.7%, P < 0.001), compared with lupus patients without HDP. A total of 35 (77.8%) HDP patients had disease activation during pregnancy. All the events occurred during the second and third trimesters, mainly presenting as moderate-to-high activity (65.7%). Active disease [odds ratios (OR) = 3.9, 95% confidential interval (CI) 1.5-9.7, P = 0.004] and positive anticardiolipin (aCL) antibody (OR = 7.6, 95% CI 2.7-18.6, P < 0.001) wer...Continue Reading

References

Nov 24, 1999·Lupus·Jill P BuyonM A Khamashta
Dec 21, 2000·Current Rheumatology Reports·B J Hunt, M A Khamashta
Mar 18, 2003·Immunobiology·Piersandro RiboldiPier Luigi Meroni
Sep 23, 2003·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·E RaschiPier Luigi Meroni
Jun 23, 2005·American Journal of Obstetrics and Gynecology·Eliza F ChakravartyMaurice L Druzin
Nov 17, 2009·American Journal of Reproductive Immunology : AJRI·Zhou JianjunZhao Xia
Jul 6, 2010·Lancet·Eric A P SteegersRobert Pijnenborg
Dec 15, 2010·Lupus·N RupertoLupus Foundation of America, Inc. International Flare Consensus Initiative
Dec 17, 2010·European Journal of Clinical Investigation·Guillermo Ruiz-Irastorza, M A Khamashta
Jun 22, 2013·Circulation Research·Yang Xia, Rodney E Kellems
Jan 31, 2014·Current Atherosclerosis Reports·Amanda R Vest, Leslie S Cho
Nov 14, 2014·Immunologic Research·Luis J JaraMiguel A Saavedra
Jun 23, 2015·Annals of Internal Medicine·Jill P BuyonJane E Salmon
Jul 6, 2016·Journal of Autoimmunity·Gabriella MoroniMarta Mosca
Feb 1, 2017·Immunologic Research·Nuria Martínez-SánchezJose Luis Bartha
Feb 7, 2017·Journal of Autoimmunity·Melissa E MunroeJudith A James

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.